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S q Udesanding the extent to which hildhood leukaemia and non-Hodgkin lymphomas are
heritable is important to the survivors of these diseases, their familis and clnicians who provide genetic
counsling Such understanding is also relevant to the possibiity raised by Gardner et al. (1990, Br. Med J.,
360, 423-429) that paternal p to irradiation may be an aetological factor in these diseases. No
malignant neoplasm was among 382 offspring of survivors of childhood lekaeMia and non-
Hodgkin lymphoma foLowed up for a median period of 5.8 years, the lrgest available cohort of such
offspring. These data indicate that it is unikely that the risk of a malignant neoplasm occurring in the
offspring exceeds eight times that expected in the geral population. Similary, the risk of leukaeia and
non-Hodgkin lymphoma among offspring is unlkely to exceed 21 times that expected. The proportion of
survivors of childhood kukaemia and non-Hodgkin lymphona with the heritable form of these dises is
unlikely to exceed 5%, assg an autosomal dinant pattern of transmission, with penetrance of at least
70% and that all heritabe cases develop by age 15 years. The best (i.e. at present most hikely) estimates of
these risks are of course much lower. There was no evidene of an excess of congenital abnormahties among
the offspring and the sex ratio was similar to that expected from the general population.
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Knowledge of the frequency of occurrence of malignant
neoplasm generally, and leukaemia and non-Hodgkin lym-
phomas in particular, among the offspnng of survivors of
leukaemia and non-Hodgkin lymphomas diagnosed in child-
hood is important in that it will provide clarification of the
extent to which these diseases are heritable. Such information
is of great importance to survivors of these diseases, their
families and the clinicians who provide genetic counselling.
This information is also relevant to the question of whether
paternal preconception irradiation is involved in the
aetiology of childhood lukaemia and non-Hodgkin lym-
phomas (Gardner et al., 1990).
Malignant neoplasms occur rarely in childhood - there are
1200 newly diagnosed patients aged under 15 each year in
Bntain. During recent decades there have been considerable
improvements in the proportion of patients surviving at least
5 years from diagnosis, and about 90% of such survivors
appear cured (Robertson et al., 1994). Until recently there
were insufficient patients surviving to provide an adequate
number of offspring to estimate their risk of developing
malignant neoplasms. As a consequence there have been few
previous studies concerned with the occurrence of malignant
neoplasms among the offspring of survivors of childhood
cancer. We report on the risk of occurrence of malignant
neoplasms within the largest available cohort of offspring of
survivors of childhood leukaemia and non-Hodgkin lym-
phoma.
Materal ad methods
Using the population-based National Registry of Childhood
Tumours, we identified 5227 patients diagnosed with cancer
below age 15 years in Britain since 1940 who were born
before 1%9 and who were still alive. A postal questionnaire
was sent mainly to the general practitioners of survivors. For
the 959 survivors treated since 1976 we initially attempted to
identify a hospital consultant who was responsible for the
clinical follow-up of the patient. If we were unable to locate
such a consultant, or if he or she did not return a satisfac-
torily compled questionnaire then we approached the
general practitioner of the patient. The questionnaire was
mainly concened with outcomes of pregnances and the
health of offspring of survivors. In this initial paper we focus
on the occurrence of malignant neoplasms among the
offspring of the subgroup of survivors diagnosed with
leukaemia or non-Hodgkin lymphoma in childhood. In
subsequent papers we shall address the question of the
heritability of other specific types of childhood cancer and
also whether there is evidnc of therapy-related germ cell
mutagenesis from consideration of the pregnances and off-
spring of survivors of all types of childhood cancer.
For the purposes of the present analysis we combined
information relating to the offspring of survivors of child-
hood leukaemia and non-Hodgkin lymphomas because the
numbers were too small to allow a meaningful analysis by
more specific diagnostic categories. This combined diagnostic
category comprises a constellation of diseases and, although
some cases of non-Hodgkin lymphoma may truly be the
same disease as some leukaemias, in general the heredity of
these different diseases may be different.
Using registration rates of malignant neoplasms occurring
throughout England and Wales, and provided on magneic
tape by the Office of Population Censuses and Surveys, we
have caculated numbers of incident malignant neoplasms
expected among the offspring using population rates stratified
by sex, age and calender period (both in 5 year intervals) and
multiplying the rate by the corresponding person-years at
risk. Similar methods were used to obtain the expected
number of deaths from all causes and also the expected
number of deaths from each of congenital abnormalities and
malignant neoplasms. Deaths from congenital abnormaities
were considered because an excess of such deaths might give
some clue concerning inherited susceptibility. From the
observed and expected numbers of a specific outcome it is
possible, using standard Poisson assumptions, to obtain an
upper (one-sided) 95% confidence bound on the relative risk
of the specific outcome among the offspring of survivors as
compared with the risk in the general population (Pearson
and Hartley, 1976).
Most human cancers can occur in individuals who are
genetically predisposed. The most readily detected pattern of
genetic susceptibility involves autosomal dominant
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inheritance with high penetrance, particularly if the cancer
appears at an unusually early age (Knudson, 1993). For the
majority of such syndromes identified, the molcular
mechanism involves tumour-suppressor genes (Knudson,
1993). There is evidence that this mechanism is involved in
the development of leukaemias associated with the
Li-Fraumeni syndrome (Malk-in, 1993).
We investigate the implications of assuming that a propor-
tion of leukaemia and non-Hodgkin lymphoma survivors
have a heritable form of these diseases and that these are
transmitted as an autosomal dominant with specified pene-
trance. In the statistical appendix we develop an expression
for the probability of the observed data on the offspring
under these assumptions. Using this expression we may
obtain an upper (one-sided) confidence bound for the pro-
portion of survivors with the heritable form of leukaemia or
non-Hodgkin lymphoma.
We compared the observed numbers of serious (ie poten-
tially lethal or handicapping congenital abnormalities occurr-
ing among offspring with those expected from some of the
most reliable sources of birth prevalence available in Britain,
and compiled by Leck (1994). The sex ratio observed among
the offspring was compared with that expected from the sex
ratio observed in the general population of England and
Wales (Office of Population Censuses and Surveys, 1991).
Result
There were 885 survivors of leukaemia or non-Hodgkin Iym-
phoma eligible for the study in that they satisfied the criteria
given above. For 852 of these we identified either a current
general practitioner or a hospital consultant and sent out a
questionnaire. A questionnaire was returned completed on
737, a response rate of 86.5%. For 51 of the survivors for
whom no questionnaire was returned we had a questionnaire
from a previous similar postal survey. From the totality of
questionnaires available there was evidence of401 live births,
though in some instances the information provided was
inadequate. After again contacting all of the general practi-
tioners responsible for survivors for whom there was inade-
quate information on offspring we ultimately obtained
sufficient information to include 382 offspring in a cohort
analysis. For inclusion in the cohort we required of each
offspring: date of birth, sex and an 'exit date', the last being
a follow-up date for which it was known whether the
offspring had ever been diagnosed with a malignant neo-
plasm. A total of 2776 person-years of follow-up were acc-
rued on the cohort of offspring. The mean and median
follow-up periods (i.e. ages at last follow-up) were 7.3 and
5.8 years respectively.
No malignant neoplasms occurred among the offspring.
The expected number based on rates of these diseases in the
general population was 0.36, which gives an upper (one-
sided) 95% confidence bound on the relative risk of malig-
nant neoplasms among the offspring of 8.4. The expected
number of leukaemias and non-Hodgkin lymphomas was
0.14: this givesan upper (one-sided) 95% confidence bound
on the relative risk of leukaemia or non-Hodgkin lymphomas
among the offspring of 21.4. The latter confidence bound is
high but is determined by the small number of offspring
available and the rarity with which these dieases are
expected to occur.
In Table I we give the upper (one-sided) 95% and 99%
confidence bounds for the proportion of survivors with
heritable leukaemia or non-Hodgkin lymphoma on the
assumption that the mode of inheritance is that of a simple
dominant gene with the indicated level of penetrance.
Separate confidence bounds are given depending on whether
it is assumed that all heritable cases will appear by age 15
years or by age 50 years. If we assume that all such cases
manifest by age 15, then, if the diseases had a penetrance of
at least 0.7, the proportion of heritable cases among the
survivors is unlikely to exceed 5%.
In Table H we give the observed and expected numbers of
deaths among the offspring. There was one death from a
Table I Upper(one-sided) 95% and 99% confidence bounds for the proportion ofsurvivors
with heritable ukaemia or non-Hodgkin lymphoma
Penetrance Upper 95% cmJdece bound Upper 99°/. cnfidence bound
a) Asswtng all heritable cases appear by age 15
1.0 0.04
0.9 0.04
0.8 0.04
0.7 0.05
0.6 0.06
0.5 0.07
0.4 0.08
0.3 0.10
0.2 0.15
b) Asming all heritable cases appear by age 50
1.0 0.12
0.9 0.13
0.8 0.15
0.7 0.17
0.6 0.19
0.5 0.23
0.4 0.29
0.3 0.38
0.2 0.57
0.06
0.06
0.07
0.08
0.09
0.10
0.12
0.16
0.24
0.19
0.20
0.23
0.26
0.30
0.36
0.45
0.59
0.89
Table H Observed and ecpected deaths among offspring of survivors ofleukaenia and non-Hodgkin
lymphomas
Observed No. Expected No. Relative risk 95% confidence interval
Cause ofdeath (0) (E) (OIE) on relative risk
Congenital abnormalities 1 0.74 1.35 (0.03, 7.54)
Malignant neoplasms 0 0.15 0.00
Other causes 6 2.61 2.30 (0.84, 5.02)
Total 7 3.51 2.00 (0.80,4.11)congenital abnormality: a tracheo-oesophageal fistula. None
of the remaimnng six deaths was due to a neoplasm or con-
genital abnormality. Two deaths were due to pneumonia in
offspring with pre-existing brain damage. three to complica-
tions of a premature delivery and one to a severe head injury:
the circumstances in which this arose are not specified.
Investigation of the congenital abnormalities occurring
among the offspring indicated that the observed frequency of
serious abnormalities was broadly similar to that expected
(Leck. 1994). However. there were four offspring. of different
parents. who were diagnosed with pyloric stenosis. If we take
the prevalence at birth as between 3 and 5 per 1000 total
births (Leck, 1994) then the expected number lies between
382 x 0.003 = 1.15 and 382 x 0.005 = 1.91. Assuming under-
lying Poisson variability then the one-tailed P-values
associated with these expected numbers are 0.03 and 0.13
respectively. Therefore, the observed number is not
sufficiently discrepant from that expected to conclude that
there is evidence of an excess.
Table III summarises the sex of offspring in relation to the
sex of their parents. There was some evidence of an excess of
male offspring born to female survivors when compared with
the sex ratio in the general population (P = 0.06. two-tailed
test) (Office of Population Censuses and Surveys, 1991).
Although this excess was apparent among the offspring of
both leukaemia and non-Hodgkin lymphoma survivors
separately, it may well be due to chance, and further inter-
pretation is not justified without independent confirmation. It
is of interest that in a previous study Fraumeni (1964)
reported that only 24 of 56 offspring of mothers diagnosed
with leukaemia. mainly acute myeloid. were male.
Harnden (1985) has concluded that the evidence that
inherited factors are important in the aetiology of leukaemia
and lymphoma is not strong. In a recent review of the
natural history of childhood acute leukaemia Greaves (1993)
has concluded that: 'inherited abnormal alleles are likely to
Table IH Sex of offspnrng in relation to sex of survivor
Sex ofsurvivor
Mfale Female Total
Sex of offspring
Male 78 130 208
Female 79 95 174
Total 157 225 382
Table IV Previous
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play a part in childhood leukaemia: their actual contribution
may well be relatively small but is almost certainly underes-
timated at present'. The most direct way to estimate the
extent of the inherited component of childhood leukaemia
and non-Hodgkin lymphoma is to study the frequency of
occurrence of these diseases among the offspring of patients
who survive. This is not entirely without problems of inter-
pretation since it might be that the group of patients who
survive and produce offspring may contain a different pro-
portion of henrtable cases to those originally diagnosed. If we
assume that such selection does not take place. then from
Table I it is apparent that, assuming that all heritable cases
occur by age 15 years, the proportion of survivors with the
heritable form of leukaemia and non-Hodgkin lymphoma is
unlikely to exceed 5%. This also assumes that the pattern of
inheritance is that of an autosomal dominant gene with
penetrance of at least 0.7.
A critical assumption underlying the derivation of the
upper confidence bound on the proportion of heritable cases
is that the age distribution for the heritable cases is propor-
tionate to that for sporadic cases (see the statistical appen-
dix). This is unlikely to be true. However, experience from
retinoblastoma indicates that heritable cases develop at
younger ages than sporadic cases (Draper et al.. 1992). and it
is reasonable to assume the same would apply to heritable
leukaemia and non-Hodgkin lymphomas. On this basis the
upper confidence bound we have estimated will almost cer-
tainly be too large. although by how much is unknown
because of uncertainty relating to the true age distribution of
the heritable cases.
The heritability of childhood leukaemia and non-Hodgkin
lymphoma has assumed considerable importance as an
occupational and public health issue as a result of the sugges-
tion that paternal preconceptual occupational exposure to
radiation at the Sellafield nuclear reprocessing plant may be
involved in the development of these diseases (Gardner et al..
1990). Recently Doll et al. (1994) have cited our previous
study of the risk of cancer among the 1348 offspring of
survivors of childhood cancer (Hawkins et al.. 1989) in sup-
port of the conclusion that occupational exposure to radia-
tion is not an aetiological factor. Our previous study included
86 survivors of leukaemia and non-Hodgkin lymphoma in
childhood who produced 158 offspring, none of whom
developed any malignant neoplasm (Hawkins et al.. 1989).
All of the offspring included in that study are included in the
present one, but with an extended period of follow-up.
Broadly, the present study confirms and extends the evidence
that inherited abnormal alleles do not appear to be impor-
tant in the aetiology of childhood leukaemia and non-
Hodgkin lymphomas under the assumed Mendelian model.
However, less restrictive or more complicated modes of
inheritance might be hypothesised which would require many
studies of cancer in offspring of survivors of childhood or adolescent leukaemia or
non-Hodgkin lymphoma (NHL)
Numbers ofoffspring
Leukaemia NHL Total
Average
follow-up
Total person-Years (nearest YearJ'
Cancers
in offspring
Mulvihill et al. 28 140 168 1691 10 Survivor-ALL
(1987) Offspring-AL
Li et al. 59 59 None
(1979)
Nygaard et al. 48 0 48 284 6 None
(1991)
Marradi et al. 23 0 23 5 None
(1982)
Green et al. 22 0 22 6 None
(1989)
Rokicka-Milewska, 7 0 7 25 4 None
et al. (1986)
Total 128 199 327
ALL, acute lymphoblastic leukaemia; AL. acute leukaemia not otherwise specified; NHL. non-Hodgkin
lymphoma; aAverage, mean or median.
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more data to test adequately. The present study strengthens
the case for the interpretation which Doll and colleagues
made relating to our earlier study.
The previous studies of the occurrence of cancer in the
offspring of survivors of childhood or adolescent leukaemia
or non-Hodgkin lymphomas are summarised in Table IV. In
total there were 327 offspring reported, among whom one
malignant neoplasm has been observed. A female survivor of
acute lymphoblastic leukaemia who was treated with multiple
chemotherapy produced a daughter who apparently died of
acute leukaemia (not otherwise specified) at 6 months of age.
In conclusion, there are at present 709 known offspring of
survivors of childhood and adolescent leukaemia or non-
Hodgkin lymphoma, 382 from our study and 327 from
previous studies, who have been followed up on average to at
least 6 years of age. One of these offspring appears to have
developed a disease similar to that successfully treated in her
mother. Unfortunately, the original investigators were unable
to contact the survivor concerned and are unable to confirm
the clinical details of the disease in the offspring (Mulvihill et
al., 1987). From our study there is no evidence of an in-
creased risk of malignant neoplasms among offspring as
compared with the general population; it is unlikely that the
risk is greater than the 8-fold expected. Furthermore, the
proportion of survivors of childhood leukaemia and non-
Hodgkin lymphomas with the heritable form of these
diseases is unlikely to exceed 5%, assuming an autosomal
dominant mode of transmission with penetrance of
70-100%. More precise estimates of the heritable component
of these diseases could be obtained by pooling the original
data from this and previous studies and using similar
methods of analysis to those adopted above.
The practical message to be derived from this and previous
studies is that, although any detailed estimates of heritability
depend on a number of unverified assumptions, and although
a degree of caution is necessary until more offspring have
been followed up, the empinrcally observed risks to offspring
are small.
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statsta appnx
As explained in the text we have used the results of this study to examine the possibility that some cases of leukaemia and non-Hodgkin
lymphoma are henrtable. Specifically, we have considered the hypothesis that in a fractionlof cases these diseases can be transmitted in a
simple autosomal dominant pattern with specified penetrance. With these assumptions a one-sided upper confidence limit forIwas calculated
using varying assumptions about the penetrance and the age distribution of heritable cases.
For the general population we denote by q(t) the probability of developing leukaemia or non-Hodgkin lymphoma by age t. We assume also
that all henrtable cases that manifest the disease do so by age T and that for these cases the age distribution is proportionate to that for similar
malignant neoplasms in the general population: then for t < T the conditional probability of the disease occurring by age t is p(t), where
p(t) = q(t) q(T); for t> T,p(t) = 1. The absolute probability of not manifesting the disease by age t, assuming a dominant pattern of inheritance
is [1-0.5 x (penetrance) x p(t)]IelablHty oc dilbood kukaemsa
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For a given family, denote the ages to which the offspring are followed up by tAi = 1,2, ). Then the probability of the observed offspring
data is:
H {A [prob (no offspnrng affected survivor carries gene)] +(I-A) [prob (no offspring affected survivor does not carry gene)])
families
= H { n [140.5) x (penetrance) xp(ti)] + (1-) n [l-q(t-)J}
families offspring (i) offspring (i)
within family within family
The q(t) values were calculated from population rates of malignant neoplasms. For values of t= 1,2, , 15 years they were calculated using
unpublished data from the National Registry of Childhood Tumours. For t= 16,17,---, 50 years they were calculated from the Leukaemia
Research Fund survey of leukaemia and lymphomas*.
The expression above has two parameters,Akand the penetrance. In Table I we give the 95% and 99% upper (one-sided) confidence bounds
on Ifor varying values of the penetrance. These confidence bounds are evaluated by finding the values k, k5 and k99, say, such that, for a
specified value of the penetrance, the probability of the observed data is 0.05 or 0.01 respectively. In Table I (a) it is assumed that all heritable
cases occur by age 15; in Table 1(b) they are assumed to occur by age 50.
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